glp-1 receptor agonists for type 2 diabetes Targeting GLP-1, GIP & GCG in Obesity and Research glp-1 and dual glp-1/gip receptor

Cureus (2023) 15(2):e35171

Proper mixing supports consistent treatment results for patients

The confusion comes from misreading the SURPASS-2 trial (Fras et al., New England Journal of Medicine 2021), which compared tirzepatide to semaglutide 1 mg in type 2 diabetes patients

Moreover, cells classified as progenitors did not show high signal for mrc1 , ncf1 and swap70a

Due to rapid technical advances, obtaining the MRS longitudinally over decades is not feasible

But there have been reports of problems blanching with water and steam, which can result in nutrient loss such as protein, polysaccharides and vitamins (88)